Crizotinib
About
Therapy type: Targeted therapy
Therapy strategy: ALK inhibition, MET inhibition, ROS1 inhibition
Mappings
NCI Thesaurus: Crizotinib (coding:ncit:C74061)
RxNorm: crizotinib (coding:rxcui:1148495, coding:omop:40242675)
SNOMED: Crizotinib (coding:sctid:703637000, coding:omop:45766472)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) HC (1) | v::ALK | Non-Small Cell Lung Cancer | Crizotinib | |
| FDA (1) HC (1) | v::ROS1 | Non-Small Cell Lung Cancer | Crizotinib | |
| FDA (1) | v::ALK | Anaplastic Large Cell Lymphoma | Crizotinib | |
| FDA (1) | v::ALK | Inflammatory Myofibroblastic Tumor | Crizotinib |